Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation
Aim. To evaluate the budgetary impact of using budesonide + formoterol (Symbicort Turbuhaler) as maintenance therapy in real clinical practice compared with standard therapy for asthma of varying severity: for mild asthma with on-demand salbutamol; for moderate and severe asthma with the drug salme...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | Russian |
| Julkaistu: |
"Consilium Medicum" Publishing house
2022-08-01
|
| Sarja: | Терапевтический архив |
| Aiheet: | |
| Linkit: | https://ter-arkhiv.ru/0040-3660/article/viewFile/109735/83978 |